Switch theme
Sign up to access all valuation multiples
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
2017
72K+
LTM Revenue $24.9B
LTM EBITDA $5.1B
$51.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Siemens Healthineers has a last 12-month revenue of $24.9B and a last 12-month EBITDA of $5.1B.
In the most recent fiscal year, Siemens Healthineers achieved revenue of $24.0B and an EBITDA of $4.5B.
Siemens Healthineers expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Siemens Healthineers valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $23.3B | $24.0B | XXX | XXX | XXX |
| Gross Profit | $8.7B | $8.3B | XXX | XXX | XXX |
| Gross Margin | 38% | 34% | XXX | XXX | XXX |
| EBITDA | $4.1B | $4.5B | XXX | XXX | XXX |
| EBITDA Margin | 17% | 19% | XXX | XXX | XXX |
| Net Profit | $2.2B | $1.6B | XXX | XXX | XXX |
| Net Margin | 9% | 7% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 23, 2025, Siemens Healthineers's stock price is EUR 45 (or $48).
Siemens Healthineers has current market cap of EUR 50.0B (or $53.7B), and EV of EUR 47.8B (or $51.3B).
See Siemens Healthineers trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $51.3B | $53.7B | XXX | XXX | XXX | XXX | $2.55 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 23, 2025, Siemens Healthineers has market cap of $53.7B and EV of $51.3B.
Siemens Healthineers's trades at 2.1x LTM EV/Revenue multiple, and 10.1x LTM EBITDA.
Analysts estimate Siemens Healthineers's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Siemens Healthineers and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $51.3B | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | 10.8x | XXX | XXX | XXX |
| P/E | 23.9x | XXX | XXX | XXX |
| P/E/Growth | 1.1x | XXX | XXX | XXX |
| EV/FCF | 20.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSiemens Healthineers's NTM/LTM revenue growth is 6%
Siemens Healthineers's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Siemens Healthineers's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Siemens Healthineers's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Siemens Healthineers and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 26% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 16% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 25% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Siemens Healthineers acquired XXX companies to date.
Last acquisition by Siemens Healthineers was XXXXXXXX, XXXXX XXXXX XXXXXX . Siemens Healthineers acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Siemens Healthineers founded? | Siemens Healthineers was founded in 2017. |
| Where is Siemens Healthineers headquartered? | Siemens Healthineers is headquartered in Germany. |
| How many employees does Siemens Healthineers have? | As of today, Siemens Healthineers has 72K+ employees. |
| Is Siemens Healthineers publicy listed? | Yes, Siemens Healthineers is a public company listed on ETR. |
| What is the stock symbol of Siemens Healthineers? | Siemens Healthineers trades under SHL ticker. |
| When did Siemens Healthineers go public? | Siemens Healthineers went public in 2018. |
| Who are competitors of Siemens Healthineers? | Similar companies to Siemens Healthineers include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Siemens Healthineers? | Siemens Healthineers's current market cap is $53.7B |
| What is the current revenue of Siemens Healthineers? | Siemens Healthineers's last 12-month revenue is $24.9B. |
| What is the current EBITDA of Siemens Healthineers? | Siemens Healthineers's last 12-month EBITDA is $5.1B. |
| What is the current EV/Revenue multiple of Siemens Healthineers? | Current revenue multiple of Siemens Healthineers is 2.1x. |
| What is the current EV/EBITDA multiple of Siemens Healthineers? | Current EBITDA multiple of Siemens Healthineers is 10.1x. |
| What is the current revenue growth of Siemens Healthineers? | Siemens Healthineers revenue growth between 2023 and 2024 was 3%. |
| Is Siemens Healthineers profitable? | Yes, Siemens Healthineers is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
